Is oocyte maturation rate associated with the dose of triptorelin used for triggering final oocyte maturation in high-risk for severe OHSS patients, undergoing ovarian stimulation.

被引：0
|
作者：
Lainas, T. G. [1 ]
Lainas, G. [1 ]
Sfontouris, I. [1 ]
Venetis, C. [2 ]
Bosdou, J. [3 ]
Chatzimeletiou, A. [3 ]
Tarlatzis, B. [3 ]
Grimbizis, G. [3 ]
Kolibianakis, E. [3 ]
机构：
[1] Eugonia, Unit Assisted Reprod, Athens, Greece
[2] Univ New South Wales, Sch Womens & Childrens Hlth, UNSW Med, Sydney, NSW, Australia
[3] Aristotle Univ Thessaloniki, Sch Med, Human Reprod Unit, Dept Obstet & Gynecol 1, Thessaloniki, Greece
来源：
HUMAN REPRODUCTION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-606
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [31] IMPLEMENTING TWO STRATEGIES TO AVOID OVARIAN HYPERSTIMULATION SYNDROME (OHSS): USE OF GnRH AGONISTS (GnRHa) TO TRIGGER FINAL OOCYTE MATURATION ASSOCIATED WITH BLASTOCYST CRYOPRESERVATION.
    Carneiro, M. M.
    Silva, A. L. M.
    Cota, A. M. M.
    Caetano, J. P. J.
    FERTILITY AND STERILITY, 2013, 100 (03) : S517 - S518
  • [32] TRIGGER OF OOCYTE MATURATION WITH LOW-DOSE HUMAN CHORIONIC GONADOTROPIN (hCG) REDUCES THE RISK OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) AND IMPROVES IVF OUTCOME.
    Ying, Y.
    Mayer, J.
    Plosker, S.
    FERTILITY AND STERILITY, 2013, 100 (03) : S264 - S264
  • [33] GnRH agonist versus rHCG for induction of final oocyte maturation in egg donors undergoing controlled ovarian stimulation with recombinant FSH and antagonist (interim analysis).
    Galindo, A.
    Vernaeve, V.
    Colodron, M.
    Guillen, J.
    Durban, M.
    Coll, O.
    FERTILITY AND STERILITY, 2006, 86 : S395 - S396
  • [34] Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy
    Abbara, Ali
    Jayasena, Channa N.
    Christopoulos, Georgios
    Narayanaswamy, Shakunthala
    Izzi-Engbeaya, Chioma
    Nijher, Gurjinder M. K.
    Comninos, Alexander N.
    Peters, Deborah
    Buckley, Adam
    Ratnasabapathy, Risheka
    Prague, Julia K.
    Salim, Rehan
    Lavery, Stuart A.
    Bloom, Stephen R.
    Szigeti, Matyas
    Ashby, Deborah A.
    Trew, Geoffrey H.
    Dhillo, Waljit S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (09): : 3322 - 3331
  • [35] Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting
    DiLuigi, Andrea J.
    Engmann, Lawrence
    Schmidt, David W.
    Maier, Donald B.
    Nulsen, John C.
    Benadiva, Claudio A.
    FERTILITY AND STERILITY, 2010, 94 (03) : 1111 - 1114
  • [36] Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support
    Imbar, Tal
    Kol, Shahar
    Lossos, Francine
    Bdolah, Yuval
    Hurwitz, A.
    Haimov-Kochman, Ronit
    HUMAN REPRODUCTION, 2012, 27 (03) : 753 - 759
  • [37] High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection
    Kyrou, Dimitra
    Kolibianakis, Efstratios M.
    Fatemi, Human M.
    Camus, Michel
    Tournaye, Herman
    Tarlatzis, Basil C.
    Devroey, Paul
    FERTILITY AND STERILITY, 2011, 96 (04) : 884 - 888
  • [38] USE OF GnRH AGONIST FOR FINAL OOCYTE MATURATION IS ASSOCIATED WITH SIMILAR ENDOCRINE PROFILES, MATURE OOCYTE YIELD, AND PREGNANCY OUTCOMES IN PCOS PATIENTS COMPARED TO OTHER HIGH RESPONDERS.
    O'Neill, K. E.
    Senapati, S.
    Dokras, A.
    FERTILITY AND STERILITY, 2013, 100 (03) : S353 - S354
  • [39] The use of GnRH agonist to trigger final stages of oocyte maturation in patients with polycystic ovarian syndrome (PCOS) and high responders during IVF treatment
    Engmann, L
    Hartnett, J
    Siano, L
    Schmidt, D
    Nulsen, J
    Maier, D
    Benadiva, C
    FERTILITY AND STERILITY, 2005, 83 : S26 - S27
  • [40] Association between body mass index and oocyte maturation in patients triggered with GnRH agonist who are at high risk for severe ovarian hyperstimulation syndrome: an observational cohort study
    Lainas, George T.
    Lainas, Tryfon G.
    Sfontouris, Ioannis A.
    Venetis, Christos A.
    Bosdou, Julia K.
    Chatzimeletiou, Aikaterini
    Grimbizis, Grigorios F.
    Tarlatzis, Basil C.
    Kolibianakis, Efstratios M.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2020, 40 (01) : 168 - 175
12345